Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 36, 2004 - Issue 1
Submit an article Journal homepage
49
Views
54
CrossRef citations to date
0
Altmetric
Original Article

Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome

Christian Østergaard From the Division of Microbiology, Department of Antibiotic Resistance and Hospital Hygiene, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Microbiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, DenmarkCorrespondence[email protected]
,
Thomas Benfield Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
,
Jens D. Lundgren Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark; Department of Copenhagen HIV Programme, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
&
Jesper Eugen-olsen Department of Clinical Research Unit, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
Pages 14-19 | Received 02 Jun 2003, Accepted 13 Oct 2003, Published online: 08 Jul 2009

  • Tauber MG, Moser B. Cytokines and chemokines in meningeal inflammation: biological and clinical implications. Clin Infect Dis 1999; 28: 1–12.
  • Cairns H, Russell DS. Cerebral artheritis and phlebitis in pneumococcal meningitis. J Pathol Bacteriol 1946; 58: 649–65.
  • Nau R, Soto A, Bruck W. Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol 1999; 58: 265–74.
  • Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin North America 2000; 13: 527–48.
  • Nau R, Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002; 25: 38–45.
  • Blasi F, Carmeliet P. uPAR: a versatile signalling orchestator. Nature 2002; 3: 932–43.
  • Cuzner ML, Opdenakker G. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 1999; 94: 1–14.
  • Sitrin RG, Pan PM, Blackwood RA, Huang J, Petty HR. Cutting edge: evidence for a signalling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils. J Immunol 2001; 166: 4822–5.
  • Sitrin RG, Todd RF, III, Albrecht E, Gyetko MR. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996; 97: 1942–51.
  • Dumler I, Stepanova V, Jerke U, Mayboroda OA, Vogel F, Bouvet P, et al. Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr Biol 1999; 9: 1468–76.
  • Rijneveld AW, Levi M, Florquin S, Speelman P, Carmeliet P, van der Poll T. Urokinase receptor is necessary for adequate host defence against pneumococcal pneumonia. J Immunol 2002; 168: 3507–11.
  • Gyetko MR, Chen GH, McDonald RA, Goodman R, Huffnagle GB, Wilkinson CC, et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J Clin Invest 1996; 97: 1818–26.
  • Fauser S, Deininger MH, Kremsner PG, Magdolen V, Luther T, Meyermann R, Schluesener HJ. Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria. J Neuroimmunol 2000; 111: 234–40.
  • Hodges GR, Perkins RL. Acute bacterial meningitis: an analysis of factors influencing prognosis. Am J Med Sci 1975; 270: 427–40.
  • Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J 1997; 16: 7279–86.
  • Wittenhagen P, Kronborg G, Weis N, Nielsen H, Obel N, Pedersen SS, Eugen-Olsen J. The plasma level of soluble urokinase plasminogen activator receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and carries strong prognostic value. CMI (in press).
  • Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, Eugen-Olsen J. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 2000; 96: 4091–5.
  • Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, et al. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int J Tuberc Lung Dis 2002; 6: 686–92.
  • Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, et al. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res 1998; 58: 1843–9.
  • Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sorensen S, Dano K, Brunner N. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 1999; 91: 869–74.
  • Garcia-Monco JC, Coleman JL, Benach JL. Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurological diseases. J Neuroimmunol 2002; 129: 216–23.
  • Winkler F, Kastenbauer S, Koedel U, Pfister HW Role of the urokinase plasminogen activator system in patients with bacterial meningitis. Neurol 2002; 59: 1350–5.
  • Østergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002; 9: 598–604.
  • Degryse B, Orlando S, Resnati M, Rabbani SA, Blasi F. Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signalling pathways. Oncogene 2001; 20: 2032–43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.